A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency

Journal of Clinical Pathology

Volumn 55, Issue 2, 2002, Pages 145-147

  Gompels, M M ^a   Lock, R J ^a   Morgan, J E ^b   Osborne, J ^b   Brown, A ^c   Virgo, P F ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c MUSGROVE PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4;

ARTICLE; COMPLEMENT COMPONENT C1S INHIBITOR DEFICIENCY; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING TEST; SEROLOGY;

EID: 0036162030     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.55.2.145     Document Type: Article

References (10)

1. C1-inhibitor and hereditary angioneurotic edema
2. Acquired C1 esterase inhibitor deficiency
3. Hereditary angioedema - Understanding the basis of C1 inhibitor deficiency
4. Hereditary angioedema
5. Response of variant hereditary angioedema phenotypes to danazol therapy
6. Hepatocelluar adenomas in patients taking danazol for hereditary angio-oedema
7. Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): Correlation between concentrations of C1-inhibitor and the forth and second components of complement
8. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate
9. Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema
10. Hereditary angioedema: Its diagnostic and management perspectives